Histogen Stock Cash Per Share
| HSTODelisted Stock | USD 0.03 0.00 0.00% |
Histogen fundamentals help investors to digest information that contributes to Histogen's financial success or failures. It also enables traders to predict the movement of Histogen Stock. The fundamental analysis module provides a way to measure Histogen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Histogen stock.
Histogen |
Histogen Company Cash Per Share Analysis
Histogen's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Histogen Cash Per Share | 5.04 X |
Most of Histogen's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Histogen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
CompetitionIn accordance with the recently published financial statements, Histogen has a Cash Per Share of 5.04 times. This is 15.86% higher than that of the Biotechnology sector and 16.4% higher than that of the Health Care industry. This indicator is about the same for all United States stocks average (which is currently at 5.01).
Histogen Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Histogen's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Histogen could also be used in its relative valuation, which is a method of valuing Histogen by comparing valuation metrics of similar companies.Histogen is currently under evaluation in cash per share category among its peers.
Histogen Fundamentals
| Return On Equity | -1.2 | |||
| Return On Asset | -0.54 | |||
| Operating Margin | (705.00) % | |||
| Current Valuation | (4.46 M) | |||
| Shares Outstanding | 4.27 M | |||
| Shares Owned By Insiders | 2.85 % | |||
| Number Of Shares Shorted | 67.03 K | |||
| Price To Book | 0.02 X | |||
| Price To Sales | 4.50 X | |||
| Revenue | 19 K | |||
| Gross Profit | (3.26 M) | |||
| EBITDA | (11.92 M) | |||
| Net Income | (12.38 M) | |||
| Cash And Equivalents | 12.6 M | |||
| Cash Per Share | 5.04 X | |||
| Total Debt | 4.63 M | |||
| Debt To Equity | 0.31 % | |||
| Current Ratio | 13.22 X | |||
| Book Value Per Share | 1.27 X | |||
| Cash Flow From Operations | (10.07 M) | |||
| Short Ratio | 4.25 X | |||
| Earnings Per Share | (2.81) X | |||
| Price To Earnings To Growth | (0.04) X | |||
| Target Price | 2.0 | |||
| Beta | 1.12 | |||
| Market Capitalization | 85.44 K | |||
| Total Asset | 19.07 M | |||
| Retained Earnings | (88.27 M) | |||
| Working Capital | 12.22 M | |||
| Net Asset | 19.07 M |
About Histogen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Histogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Histogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Histogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Histogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Histogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will appreciate offsetting losses from the drop in the long position's value.Moving against Histogen Stock
The ability to find closely correlated positions to Histogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Histogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Histogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Histogen to buy it.
The correlation of Histogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Histogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Histogen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Histogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Histogen Stock
If you are still planning to invest in Histogen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Histogen's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |